BIORESTORATIVE THERAPIES, INC. Derivative, Gain (Loss) on Derivative, Net
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Derivative, Gain (Loss) on Derivative, Net of $1.22 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2026-05-14
- BIORESTORATIVE THERAPIES, INC. derivative, gain (loss) on derivative, net for the quarter ending 2026-03-31 was $1.22M.
- BIORESTORATIVE THERAPIES, INC. derivative, gain (loss) on derivative, net for the quarter ending 2025-12-31 was $568.97K, a 39.13% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. derivative, gain (loss) on derivative, net for the quarter ending 2025-09-30 was $612.06K, a 40.95% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. derivative, gain (loss) on derivative, net for the quarter ending 2025-06-30 was $574.59K.
- BIORESTORATIVE THERAPIES, INC. derivative, gain (loss) on derivative, net for fiscal 2025 was $1.12M, a 1053.95% increase from fiscal 2024.
- BIORESTORATIVE THERAPIES, INC. derivative, gain (loss) on derivative, net for fiscal 2024 was $97.19K, a 97.57% decline from fiscal 2023.
- BIORESTORATIVE THERAPIES, INC. derivative, gain (loss) on derivative, net for fiscal 2023 was $4.00M.
- BIORESTORATIVE THERAPIES, INC. derivative, gain (loss) on derivative, net for fiscal 2020 was -$2.14M, a 371.38% decline from fiscal 2019.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 3 month as first filed | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $1.22M 10-Q · filed 2026-05-14 | $1.79M derived: sum of 2 quarters · filed 2026-05-14 | $2.40M derived: sum of 3 quarters · filed 2026-05-14 | $2.98M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-12-31 | $568.97K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.18M derived: sum of 2 quarters · filed 2026-03-26 | $1.76M derived: sum of 3 quarters · filed 2026-03-26 | $1.12M 10-K · filed 2026-03-26 | |
| 2025-09-30 | $612.06K 10-Q · filed 2025-11-12 | $1.19M derived: sum of 2 quarters · filed 2025-11-12 | $552.54K 10-Q · filed 2025-11-12 | $1.49M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-06-30 | $574.59K 10-Q · filed 2025-08-12 | -$59.53K 10-Q · filed 2025-08-12 | $875.13K derived: sum of 3 quarters · filed 2026-05-14 | $1.91M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2025-03-31 | -$634.12K 10-Q · filed 2026-05-14 | $300.54K derived: sum of 2 quarters · filed 2026-05-14 | $1.34M derived: sum of 3 quarters · filed 2026-05-14 | -$399.61K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $934.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.97M derived: sum of 2 quarters · filed 2026-03-26 | $234.51K derived: sum of 3 quarters · filed 2026-03-26 | $97.19K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $1.04M 10-Q · filed 2025-11-12 | -$700.15K derived: sum of 2 quarters · filed 2025-11-12 | -$837.47K 10-Q · filed 2025-11-12 | -$316.24K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$1.74M 10-Q · filed 2025-08-12 | -$1.87M 10-Q · filed 2025-08-12 | -$1.35M derived: sum of 3 quarters · filed 2025-08-12 | $6.34M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | -$137.32K 10-Q · filed 2025-05-14 | $383.90K derived: sum of 2 quarters · filed 2025-05-14 | $8.08M derived: sum of 3 quarters · filed 2025-05-14 | $5.35M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $521.22K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $8.21M derived: sum of 2 quarters · filed 2025-03-28 | $5.49M derived: sum of 3 quarters · filed 2025-03-28 | $4.00M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $7.69M 10-Q · filed 2024-11-12 | $4.96M derived: sum of 2 quarters · filed 2024-11-12 | $3.48M 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$2.73M 10-Q · filed 2024-08-13 | -$4.22M 10-Q · filed 2024-08-13 | |||
| 2023-03-31 | -$1.49M 10-Q · filed 2024-06-11 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $0.00 derived: sum of 2 quarters · filed 2022-03-30 | -$4.28M derived: sum of 3 quarters · filed 2022-03-30 | -$2.14M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$4.28M derived: sum of 2 quarters · filed 2021-11-15 | -$2.14M 10-Q · filed 2021-11-15 | -$1.08M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | -$4.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$2.14M 10-Q · filed 2021-08-16 | -$1.08M derived: sum of 3 quarters · filed 2021-08-16 | -$1.15M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $2.14M 10-Q · filed 2021-05-17 | -$2.14M 10-Q · filed 2021-03-29 | $3.20M derived: sum of 2 quarters · filed 2021-05-17 | $3.13M derived: sum of 3 quarters · filed 2021-05-17 | $2.98M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-30 | $992.28K derived: sum of 2 quarters · filed 2021-04-30 | $835.23K derived: sum of 3 quarters · filed 2021-04-30 | $788.97K 10-K · filed 2021-04-30 | |
| 2019-09-30 | -$65.04K 10-Q · filed 2021-04-12 | -$222.09K derived: sum of 2 quarters · filed 2021-04-12 | -$268.35K 10-Q · filed 2021-04-12 | $59.60K derived: sum of 4 quarters · filed 2021-04-12 | |
| 2019-06-30 | -$157.05K 10-Q · filed 2021-04-12 | -$203.31K 10-Q · filed 2021-04-12 | $124.64K derived: sum of 3 quarters · filed 2021-04-12 | -$490.68K derived: sum of 4 quarters · filed 2021-04-12 | |
| 2019-03-31 | -$46.26K 10-Q · filed 2021-03-29 | $281.69K derived: sum of 2 quarters · filed 2021-03-29 | -$333.63K derived: sum of 3 quarters · filed 2021-03-29 | -$440.41K derived: sum of 4 quarters · filed 2021-03-29 | |
| 2018-12-31 | $327.95K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$287.37K derived: sum of 2 quarters · filed 2021-03-18 | -$394.14K derived: sum of 3 quarters · filed 2021-03-18 | -$229.32K 10-K · filed 2021-03-18 | |
| 2018-09-30 | -$615.32K 10-Q · filed 2019-11-13 | -$722.09K derived: sum of 2 quarters · filed 2019-11-13 | -$557.27K 10-Q · filed 2019-11-13 | -$434.92K derived: sum of 4 quarters · filed 2019-11-13 | |
| 2018-06-30 | -$106.77K 10-Q · filed 2019-08-14 | $58.05K 10-Q · filed 2019-08-14 | $180.40K derived: sum of 3 quarters · filed 2019-08-14 | $165.09K derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $164.82K 10-Q · filed 2019-05-15 | $287.17K derived: sum of 2 quarters · filed 2019-05-15 | $271.86K derived: sum of 3 quarters · filed 2019-05-15 | ||
| 2017-12-31 | $122.35K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $107.04K derived: sum of 2 quarters · filed 2019-03-29 | $107.04K 10-K · filed 2019-03-29 | ||
| 2017-09-30 | -$15.31K 10-Q · filed 2018-11-13 | -$15.31K 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |